SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹1,051 Cr | ₹134,149 Cr | ₹1,321 Cr | ₹1,010 Cr | ₹834 Cr |
| Sales | ₹1,024 Cr | ₹128,601 Cr | ₹1,254 Cr | ₹949 Cr | ₹774 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹9.94 Cr | ₹4,626 Cr | ₹54 Cr | ₹46 Cr | ₹44 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹17 Cr | ₹922 Cr | ₹13 Cr | ₹14 Cr | ₹17 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹1,051 Cr | ₹134,033 Cr | ₹1,320 Cr | ₹1,010 Cr | ₹834 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹49 Cr | ₹-2,094 Cr | ₹-60 Cr | ₹-8.37 Cr | ₹-11 Cr |
| Raw Material Consumed | ₹263 Cr | ₹42,391 Cr | ₹454 Cr | ₹306 Cr | ₹236 Cr |
| Opening Raw Materials | ₹77 Cr | ₹7,290 Cr | ₹51 Cr | ₹35 Cr | ₹30 Cr |
| Purchases Raw Materials | ₹231 Cr | ₹42,845 Cr | ₹475 Cr | ₹323 Cr | ₹241 Cr |
| Closing Raw Materials | ₹46 Cr | ₹7,744 Cr | ₹72 Cr | ₹51 Cr | ₹35 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹48 Cr | ₹7,393 Cr | ₹60 Cr | ₹44 Cr | ₹38 Cr |
| Electricity & Power | ₹48 Cr | ₹7,393 Cr | ₹60 Cr | ₹44 Cr | ₹38 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹135 Cr | ₹11,825 Cr | ₹100 Cr | ₹76 Cr | ₹65 Cr |
| Salaries, Wages & Bonus | ₹120 Cr | ₹10,671 Cr | ₹91 Cr | ₹68 Cr | ₹58 Cr |
| Contributions to EPF & Pension Funds | ₹7.36 Cr | ₹617 Cr | ₹5.21 Cr | ₹4.18 Cr | ₹3.35 Cr |
| Workmen and Staff Welfare Expenses | ₹3.35 Cr | ₹315 Cr | ₹2.52 Cr | ₹2.42 Cr | ₹2.57 Cr |
| Other Employees Cost | ₹4.43 Cr | ₹222 Cr | ₹2.21 Cr | ₹1.86 Cr | ₹1.52 Cr |
| Other Manufacturing Expenses | ₹88 Cr | ₹10,962 Cr | ₹129 Cr | ₹105 Cr | ₹84 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹57 Cr | ₹1,708 Cr | ₹22 Cr | ₹20 Cr | ₹15 Cr |
| Packing Material Consumed | ₹3.18 Cr | ₹617 Cr | ₹5.05 Cr | ₹4.38 Cr | ₹3.87 Cr |
| Other Mfg Exp | ₹29 Cr | ₹8,637 Cr | ₹102 Cr | ₹81 Cr | ₹65 Cr |
| General and Administration Expenses | ₹27 Cr | ₹3,387 Cr | ₹29 Cr | ₹28 Cr | ₹26 Cr |
| Rent , Rates & Taxes | ₹1.67 Cr | ₹46 Cr | ₹0.33 Cr | ₹1.28 Cr | ₹2.51 Cr |
| Insurance | ₹11 Cr | ₹886 Cr | ₹7.11 Cr | ₹7.23 Cr | ₹5.99 Cr |
| Printing and stationery | - | ₹76 Cr | ₹0.36 Cr | ₹0.36 Cr | ₹0.44 Cr |
| Professional and legal fees | ₹4.12 Cr | ₹544 Cr | ₹4.09 Cr | ₹4.38 Cr | ₹2.53 Cr |
| Traveling and conveyance | ₹9.37 Cr | ₹857 Cr | ₹6.87 Cr | ₹6.40 Cr | ₹6.18 Cr |
| Other Administration | ₹1.29 Cr | ₹979 Cr | ₹10 Cr | ₹8.08 Cr | ₹8.33 Cr |
| Selling and Distribution Expenses | ₹10 Cr | ₹1,764 Cr | ₹20 Cr | ₹11 Cr | ₹9.43 Cr |
| Advertisement & Sales Promotion | ₹3.48 Cr | ₹349 Cr | ₹1.88 Cr | ₹1.84 Cr | ₹3.60 Cr |
| Sales Commissions & Incentives | ₹1.99 Cr | ₹138 Cr | ₹1.59 Cr | ₹1.62 Cr | ₹2.04 Cr |
| Freight and Forwarding | - | ₹1,276 Cr | ₹16 Cr | ₹7.07 Cr | ₹3.79 Cr |
| Handling and Clearing Charges | ₹4.99 Cr | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹24 Cr | ₹990 Cr | ₹6.37 Cr | ₹5.16 Cr | ₹1.08 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | ₹0.07 Cr | ₹0.65 Cr | ₹0.20 Cr | - | ₹0.02 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹24 Cr | ₹989 Cr | ₹6.17 Cr | ₹5.16 Cr | ₹1.06 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹646 Cr | ₹76,617 Cr | ₹739 Cr | ₹567 Cr | ₹449 Cr |
| Operating Profit (Excl OI) | ₹406 Cr | ₹57,416 Cr | ₹582 Cr | ₹443 Cr | ₹385 Cr |
| Other Income | ₹62 Cr | ₹4,636 Cr | ₹92 Cr | ₹14 Cr | ₹18 Cr |
| Interest Received | ₹1.93 Cr | ₹583 Cr | ₹0.07 Cr | ₹0.27 Cr | ₹0.36 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | ₹0.00 Cr | ₹0.03 Cr | ₹0.08 Cr |
| Profits on sale of Investments | - | ₹1,569 Cr | ₹74 Cr | ₹3.33 Cr | ₹6.23 Cr |
| Provision Written Back | ₹0.27 Cr | ₹12 Cr | ₹0.37 Cr | - | ₹0.15 Cr |
| Foreign Exchange Gains | ₹8.12 Cr | ₹2,144 Cr | ₹16 Cr | ₹9.56 Cr | ₹11 Cr |
| Others | ₹52 Cr | ₹329 Cr | ₹1.10 Cr | ₹1.05 Cr | ₹0.26 Cr |
| Operating Profit | ₹468 Cr | ₹62,053 Cr | ₹674 Cr | ₹457 Cr | ₹403 Cr |
| Interest | ₹7.45 Cr | ₹1,281 Cr | ₹8.53 Cr | ₹12 Cr | ₹23 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹2.87 Cr | ₹530 Cr | ₹5.92 Cr | ₹8.68 Cr | ₹17 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹3.34 Cr | ₹737 Cr | ₹2.30 Cr | ₹2.52 Cr | ₹3.15 Cr |
| Other Interest | ₹1.24 Cr | ₹14 Cr | ₹0.31 Cr | ₹0.47 Cr | ₹2.79 Cr |
| PBDT | ₹460 Cr | ₹60,772 Cr | ₹666 Cr | ₹446 Cr | ₹380 Cr |
| Depreciation | ₹55 Cr | ₹4,799 Cr | ₹39 Cr | ₹32 Cr | ₹24 Cr |
| Profit Before Taxation & Exceptional Items | ₹406 Cr | ₹55,973 Cr | ₹626 Cr | ₹414 Cr | ₹356 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹406 Cr | ₹55,973 Cr | ₹668 Cr | ₹468 Cr | ₹405 Cr |
| Provision for Tax | ₹105 Cr | ₹14,844 Cr | ₹214 Cr | ₹105 Cr | ₹88 Cr |
| Current Income Tax | ₹100 Cr | ₹14,627 Cr | ₹190 Cr | ₹102 Cr | ₹89 Cr |
| Deferred Tax | ₹6.59 Cr | ₹434 Cr | ₹23 Cr | ₹3.62 Cr | ₹-1.30 Cr |
| Other taxes | ₹-0.78 Cr | ₹-217 Cr | - | ₹0.18 Cr | - |
| Profit After Tax | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹1,465 Cr | ₹127,271 Cr | ₹936 Cr | ₹615 Cr | ₹391 Cr |
| Appropriations | ₹1,765 Cr | ₹168,400 Cr | ₹1,390 Cr | ₹978 Cr | ₹708 Cr |
| General Reserves | - | ₹1,500 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | ₹13 Cr |
| Other Appropriation | ₹0.32 Cr | ₹5,110 Cr | ₹26 Cr | ₹0.84 Cr | ₹0.82 Cr |
| Equity Dividend % | - | ₹600.00 | ₹500.00 | ₹200.00 | ₹500.00 |
| Earnings Per Share | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹24.91 |
| Adjusted EPS | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹12.45 |
Compare Income Statement of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹21,592.0 Cr | -1.1% | -28.2% | -55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -1.1% |
-28.2% |
-55.4% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses